(3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide

C25H29ClN4O2 — CID 30153628

IUPAC(3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide
SMILESCc1ccc(N2CCC[C@@H](C(=O)N(Cc3nc(-c4ccc(Cl)cc4)no3)C(C)C)C2)cc1
InChIInChI=1S/C25H29ClN4O2/c1-17(2)30(16-23-27-24(28-32-23)19-8-10-21(26)11-9-19)25(31)20-5-4-14-29(15-20)22-12-6-18(3)7-13-22/h6-13,17,20H,4-5,14-16H2,1-3H3/t20-/m1/s1
InChIKeyDJQXKZFEJGNTRR-HXUWFJFHSA-N
MW452.99 g/mol
LogP5.35
Rot. Bonds6

About (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide

(3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide (PubChem CID 30153628) has the molecular formula C25H29ClN4O2 and a molecular weight of 452.99 g/mol. Its IUPAC name is (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide.

Molecular Properties

Compound Name(3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide
PubChem CID30153628
Molecular FormulaC25H29ClN4O2
Molecular Weight452.99 g/mol
Exact Mass452.20
IUPAC Name(3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide
SMILESCc1ccc(N2CCC[C@@H](C(=O)N(Cc3nc(-c4ccc(Cl)cc4)no3)C(C)C)C2)cc1
InChIInChI=1S/C25H29ClN4O2/c1-17(2)30(16-23-27-24(28-32-23)19-8-10-21(26)11-9-19)25(31)20-5-4-14-29(15-20)22-12-6-18(3)7-13-22/h6-13,17,20H,4-5,14-16H2,1-3H3/t20-/m1/s1
InChIKeyDJQXKZFEJGNTRR-HXUWFJFHSA-N
XLogP5.35
TPSA62.47 Ų
H-Bond Donors
H-Bond Acceptors5
Rotatable Bonds6
Heavy Atoms32
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500452.99
LogP ≤ 55.35
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'anil_di_alk_E(186)', 'substructure': 'N/A'}

Analyze (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide?
The IUPAC name of (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide (CID 30153628) is (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide.
What is the SMILES notation for (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide?
The canonical SMILES for (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide is Cc1ccc(N2CCC[C@@H](C(=O)N(Cc3nc(-c4ccc(Cl)cc4)no3)C(C)C)C2)cc1.
What is the InChIKey of (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide?
The InChIKey is DJQXKZFEJGNTRR-HXUWFJFHSA-N. The full InChI is InChI=1S/C25H29ClN4O2/c1-17(2)30(16-23-27-24(28-32-23)19-8-10-21(26)11-9-19)25(31)20-5-4-14-29(15-20)22-12-6-18(3)7-13-22/h6-13,17,20H,4-5,14-16H2,1-3H3/t20-/m1/s1.
What are the key properties of (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide?
(3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide has a molecular weight of 452.99 g/mol, XLogP of 5.35, 6 rotatable bonds, 0 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for (3R)-N-[[3-(4-chlorophenyl)-1,2,4-oxadiazol-5-yl]methyl]-1-(4-methylphenyl)-N-propan-2-ylpiperidine-3-carboxamide is sourced from PubChem (CID 30153628), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).